Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿°Áõ¼º °Ç¼º¾È °¨º°Áø´ÜÀ» À§ÇÑ °Ë»ç¹ý Screening Method for Inflammatory Dry Eye

´ëÇѽðúÇÐȸÁö 2019³â 21±Ç 3È£ p.389 ~ 399
¹Ú¹ÎÇý, ¹ÚÁ¤Àº, º¯Àå¿ø, ÃÖ¹ÎÁö, Á¶ÀÏÈÆ, Á¤¸íÁø, À̱ºÀÚ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¹ÎÇý ( Park Min-Hye ) 
À»Áö´ëÇб³ º¸°Ç´ëÇпø ¾È°æ±¤Çаú

¹ÚÁ¤Àº ( Park Jung-Eun ) 
À»Áö´ëÇб³ º¸°Ç´ëÇпø ¾È°æ±¤Çаú
º¯Àå¿ø ( Byun Jang-Won ) 
°ø¾È°úÀÇ¿ø
ÃÖ¹ÎÁö ( Choi Min-Ji ) 
À»Áö´ëÇб³ ´ëÇпø º¸°ÇÇаú
Á¶ÀÏÈÆ ( Cho Il-Hoon ) 
À»Áö´ëÇб³ ÀÓ»óº´¸®Çаú
Á¤¸íÁø ( Jeong Myeong-Jin ) 
À»Áö´ëÇб³ º¸°Çȯ°æ¾ÈÀüÇаú
À̱ºÀÚ ( Lee Koon-Ja ) 
À»Áö´ëÇб³ ¾È°æ±¤Çаú

Abstract

¸ñÀû: ´«¹°°Ë»ç, °¢¸·¿°»ö ¹× °á¸·ÃæÇ÷ °Ë»ç¸¦ ÅëÇØ ¿°Áõ¼º °Ç¼º¾È °¨º°Áø´ÜÀ» À§ÇÑ ¾Ë°í¸®ÁòÀ» Á¦½ÃÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý: ¾ÈÁúȯÀÌ ¾ø´Â 20~30´ë ÃÑ 81¸íÀ» ´ë»óÀ¸·Î ¿°Áõ »ýü Ç¥ÁöÀÚÀÎ MMP-9À» ÀÌ¿ëÇÏ¿© ¿°Áõ¼º °Ç¼º¾ÈÀ» ÆǺ°ÇÏ°í, ½¬¸£¸Ó°Ë»ç, TBUT, OSDI, °¢¸· ¿°»ö, °á¸· ÃæÇ÷ °Ë»ç¸¦ ½Ç½ÃÇÏ¿´´Ù. °Ç¼º¾È ÆÇ´Ü ±âÁØÀº Schirmer test 5 mm ¹Ì¸¸, ´«¹°¸·Æı«½Ã°£ 5ÃÊ ¹Ì¸¸, °Ç¼º¾È ÀÚ°¢Áõ»ó Á¡¼ö 12Á¡ ÀÌ»ó, °¢¸·½ºÅ×ÀÌ´× ¹× °á¸·ÃæÇ÷Àº CCLRU Grade 1 ÀÌ»óÀ¸·Î ÇÏ¿´´Ù. °¢°¢ÀÇ °Ë»ç¿Í MMP-9ÀÇ »ó°ü¼ºÀº Ä«ÀÌÁ¦°ö°ËÁ¤À¸·Î È®Àκ¸°í ¿°Áõ¼º °Ç¼º¾È °¨º°Áø´ÜÀÇ ¾Ë°í¸®Áò¿¡ ´ëÇÑ ¹Î°¨µµ(sensitivity)¿Í ƯÀ̵µ(specificity) ¹× °î¼±¾Æ·¡¸éÀûÀº ROC Ä¿ºê¸¦ ÀÌ¿ëÇÏ¿´´Ù.

°á°ú: ½¬¸£¸Ó°Ë»ç¿Í TBUT °ªÀº MMP-9 ¾ç¼º ¹ÝÀÀ°ú »ó°ü¼ºÀÌ ¾ø¾ú°í(p>0.050), OSDI, °¢¸· ¿°»ö, °á¸· ÃæÇ÷Àº MMP-9 ¾ç¼º ¹ÝÀÀ°ú À¯ÀÇÇÑ »ó°ü¼ºÀ» º¸¿´´Ù(p<0.050). ¿°Áõ¼º °Ç¼º¾È °¨º°Áø´Ü¿¡ ´ëÇÑ ¹Î°¨µµ, ƯÀ̵µ, AUC´Â ¡®OSDI/°¢¸· ¿°»ö/°á¸· ÃæÇ÷¡¯ ¸ðµÎ ¹Ý¿µÇÑ °æ¿ì 44.00%, 100.00%, 0.720·Î ³ªÅ¸³µÀ¸¸ç, ¡®OSDI/°¢¸· ¿°»ö¡¯Àº 44.00%, 94.59%, 0.693, ¡®OSDI/°á¸· ÃæÇ÷¡¯Àº 76.80%, 75.68%, 0.762, ¡®°¢¸· ¿°»ö/°á¸· ÃæÇ÷¡¯Àº 52.80%, 97.30%, 0.750·Î ¡®OSDI/°á¸· ÃæÇ÷¡¯À» ¹Ý¿µÇÑ °æ¿ì°¡ °¡Àå ³ôÀº Á¤È®µµ¸¦ º¸¿´´Ù.

°á·Ð: ¡®OSDI/°á¸· ÃæÇ÷¡¯ °Ë»ç ¾Ë°í¸®ÁòÀº MMP-9 °Ë»ç°á°ú¿Í À¯»çÇÑ ³ôÀº Á¤È®µµ¸¦ º¸¿© ¿°Áõ¼º °Ç¼º¾ÈÀÇ °¨º°Áø´Ü¿¡ À¯¿ëÇÒ °ÍÀ¸·Î Á¦¾ÈÇÑ´Ù.

Purpose: To propose an algorithm for screening of inflammatory dry eye using tear tests, corneal staining and conjunctival hyperemia

Methods: A total of 81 patients in 20-30s without ophthalmologic diseases participated. The inflammatory dry eyes were diagnosed using MMP-9 (metalloproteinase-9) test and performed Shirmer test, TBUT (tear break-up time), corneal staining and conjunctival hyperemia. Dry eye refers to the criteria which specifies the OSDI (ocular surface disease index) score of more than 12, TBUT (tear film break-up time) of less 5 seconds, Schirmer test without anesthesia of less than 5mm/5minutes, corneal staining, and conjunctival hyperemia more than grade 1. Chi-square test was used to find out the correlation between tear/ocular surface test and MMP-9 test, and ROC curve was used for the sensitivity, specificity and AUC (area under the curve) for the algorithm of inflammatory dry eye.

Results: Neither of the methods, Schirmer test nor TBUT, showed statistically significant correlation with positive MMP-9 results(p>0.050). And, OSDI, corneal staining, and conjunctival hyperemia were significantly correlated with MMP-9 result(p<0.050). Among the OSDI scores, corneal staining, and conjunctival hyperemia, the sensitivity, specificity, and AUC for screening of inflammatory dry eye were as follows. The sensitivity, specificity, and AUC of ¡®OSDI/corneal staining/conjunctival hyperemia¡¯ were 44.00%, 100.00%, 0.720, and ¡®OSDI/corneal staining¡¯ were 44.00% 94.59%, 0.693, ¡®OSDI/conjunctival hyperemia¡¯ were 76.80%, 75.68%, 0.762, and ¡®corneal staining/conjunctival hyperemia were 52.80% 97.30%, 0.750, respectively, showing that ¡®OSDI/conjunctival hyperemia¡¯ was highest accuracy.

Conclusion: The algorithm of ¡®OSDI/conjunctival hyperemia¡¯ showed high accuracy similar to MMP-9 test. It would be a useful method for screening inflammatory dry eye.

Å°¿öµå

°á¸·ÃæÇ÷; °¢¸·¿°»ö; °Ç¼º¾È; ¿°Áõ¼º °Ç¼º¾È; MMP-9; OSDI
Conjunctival hyperemia; Corneal staining; Dry eye; Inflammatory; MMP-9; OSDI

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI